Kings Point Capital Management’s Precigen PGEN Stock Holding History

Kings Point Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,500	Closed	-$10K	–	563
2021 Q1	$10K	Hold	1,500	–	–	﹤0.01%	535
2020 Q4	$15K	Buy	+1,500	New	+$9.72K	﹤0.01%	452
2019 Q3	–	Sell	-1,500	Closed	-$11K	–	488
2019 Q2	$11K	Buy	+1,500	New	+$8.08K	﹤0.01%	418
2018 Q4	–	Sell	-1,500	Closed	-$26K	–	361
2018 Q3	$26K	Hold	1,500	–	–	﹤0.01%	299
2018 Q2	$21K	Hold	1,500	–	–	﹤0.01%	310
2018 Q1	$23K	Buy	+1,500	New	+$21.4K	﹤0.01%	305

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kings Point Capital Management's PGEN Position: Q2 2021 in Review

Kings Point Capital Management sold out of Precigen (PGEN) in Q2 2021, closing a stake of 1,500 shares — an estimated $10K sold.

Kings Point Capital Management first reported a position in PGEN in Q1 2018 and held it in 6 quarters. The position peaked at $26K in Q3 2018. 150 funds tracked by Wall St. Rank hold PGEN as of Q2 2021.

Kings Point Capital Management reported no remaining Precigen position as of Q2 2021 after selling out during the quarter.
Kings Point Capital Management sold 1,500 Precigen shares in Q2 2021, an estimated $10K.
Kings Point Capital Management first reported a position in Precigen in Q1 2018 and held it in 6 quarters.
Kings Point Capital Management's Precigen position peaked at $26K in Q3 2018.
150 funds tracked by Wall St. Rank held Precigen as of Q2 2021.

Based on Kings Point Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.